ReviewTherapeutic advances in drug safety2021

Neurocognitive effects associated with proprotein convertase subtilisin-kexin type 9 inhibitor use: a narrative review.

Wei C Yuet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.